º£½ÇÊÓÆµ

Oops.

Our website is temporarily unavailable in your location.

We are working hard to get it back online.

PRIVACY
Manufacturing

Hexigone Inhibitors looking to drive global sales on new six-figure equity round

The Baglan firm has raised £800,000 through a new investment round

Dr Patrick Dodds managing director of Hexigone

Baglan-based advanced manufacturer Hexigone Inhibitors is looking to accelerate its global expansion plans following a six-figure equity investment round boost.

Its latest £800,000 round was backed by early venture capital firm Waterspring Ventures (£257,000), alongside The Angel CoFund, Oxford Innovation Finance, and the Development Bank of Wales. The deal marks Waterspring’s third investment following equity injections into Welsh firms Operati and Tourhub. Cardiff-based

Waterspring is now looking to raise a new £2m fund from high net worth individuals to back early stage EIS (Enterprise Investment Scheme) eligible with firms revenues of £100,000 to £1m.

Law firm Hugh James advised on the deal.

Hexigone is addressing a global problem with its micro-reservoir technology that is added to paints and protective coatings to prevent corrosion.

Read More : Huge investment plans for the port of Port Talbot

Read More: The huge impact of manufacturing on the Welsh economy

The £32bn anticorrosive coatings industry’s most effective corrosion inhibitor - hexavalent chromate - is being banned in the EU and phased out globally due to being carcinogenic, with the sustainable alternative zinc phosphate, - known to be less effective.